Reverses autophagic dysfunction of plaques, enhances phagocytosis of p62-rich protein aggregates, inhibits macrophage apoptosis and pro-inflammatory IL-1b levels, thereby reducing atherosclerosis. This evidence concerns the gene SQSTM1 and atherosclerosis.